AMY FREEMAN: Open Payments
NPI 1255707592 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 34 payments from 9 companies in 2025. Trend: 2023 $942 · 2024 $536 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $197 |
| PFIZER INC. | 18 | $190 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
Products named: NURTEC ODT, VRAYLAR, REXULTI, QULIPTA, JOURNAVX, Dexcom G6 Transmitter, MOUNJARO, Cologuard Collection Kit.
Industry payments across IA — which companies pay providers there.
